OBJECTIVE: To articulate the need for a new approach to primary ovarian insufficiency. The condition, also known as premature menopause or premature ovarian failure, is defined by the presence of menopausal-level serum gonadotropins in association with irregular menses in adolescent girls or women younger than 40 years. It can be iatrogenic as related to cancer therapy or may arise spontaneously, either alone or as part of a host of ultrarare syndromes. In a large percentage of spontaneous cases no pathogenic mechanism can be identified. DESIGN: Literature review and consensus building at a multidisciplinary scientific workshop. CONCLUSION(S): There are major gaps in knowledge regarding the etiologic mechanisms, psychosocial effects, natural history, and medical and psychosocial management of primary ovarian insufficiency. An international research consortium and disease registry formed under the guidance of an umbrella organization would provide a pathway to comprehensively increase basic and clinical knowledge about the condition. Such a consortium and patient registry also would provide clinical samples and clinical data with a goal toward defining the specific pathogenic mechanisms. An international collaborative approach that combines the structure of a patient registry with the principles of integrative care and community-based participatory research is needed to advance the field of primary ovarian insufficiency.
OBJECTIVE: To articulate the need for a new approach to primary ovarian insufficiency. The condition, also known as premature menopause or premature ovarian failure, is defined by the presence of menopausal-level serum gonadotropins in association with irregular menses in adolescent girls or women younger than 40 years. It can be iatrogenic as related to cancer therapy or may arise spontaneously, either alone or as part of a host of ultrarare syndromes. In a large percentage of spontaneous cases no pathogenic mechanism can be identified. DESIGN: Literature review and consensus building at a multidisciplinary scientific workshop. CONCLUSION(S): There are major gaps in knowledge regarding the etiologic mechanisms, psychosocial effects, natural history, and medical and psychosocial management of primary ovarian insufficiency. An international research consortium and disease registry formed under the guidance of an umbrella organization would provide a pathway to comprehensively increase basic and clinical knowledge about the condition. Such a consortium and patient registry also would provide clinical samples and clinical data with a goal toward defining the specific pathogenic mechanisms. An international collaborative approach that combines the structure of a patient registry with the principles of integrative care and community-based participatory research is needed to advance the field of primary ovarian insufficiency.
Authors: Corrine K Welt; Alberto Falorni; Ann E Taylor; Kathryn A Martin; Janet E Hall Journal: J Clin Endocrinol Metab Date: 2005-02-10 Impact factor: 5.958
Authors: Scott Oster; Stephen Langella; Shannon Hastings; David Ervin; Ravi Madduri; Joshua Phillips; Tahsin Kurc; Frank Siebenlist; Peter Covitz; Krishnakant Shanbhag; Ian Foster; Joel Saltz Journal: J Am Med Inform Assoc Date: 2007-12-20 Impact factor: 4.497
Authors: Allison A Groff; Sharon N Covington; Lynn R Halverson; O Ray Fitzgerald; Vien Vanderhoof; Karim Calis; Lawrence M Nelson Journal: Fertil Steril Date: 2005-06 Impact factor: 7.329
Authors: Nahrain H Alzubaidi; Heather L Chapin; Vien H Vanderhoof; Karim Anton Calis; Lawrence M Nelson Journal: Obstet Gynecol Date: 2002-05 Impact factor: 7.661
Authors: Michael D Wittenberger; Randi J Hagerman; Stephanie L Sherman; Allyn McConkie-Rosell; Corrine K Welt; Robert W Rebar; Emily C Corrigan; Joe Leigh Simpson; Lawrence M Nelson Journal: Fertil Steril Date: 2006-10-30 Impact factor: 7.329
Authors: Vaishali B Popat; Karim A Calis; Vien H Vanderhoof; Giovanni Cizza; James C Reynolds; Nancy Sebring; James F Troendle; Lawrence M Nelson Journal: J Clin Endocrinol Metab Date: 2009-04-28 Impact factor: 5.958
Authors: Carrie L Nieman; Karen E Kinahan; Susan E Yount; Sarah K Rosenbloom; Kathleen J Yost; Elizabeth A Hahn; Timothy Volpe; Kimberley J Dilley; Laurie Zoloth; Teresa K Woodruff Journal: Cancer Treat Res Date: 2007
Authors: Wassim Chemaitilly; Ann C Mertens; Pauline Mitby; John Whitton; Marilyn Stovall; Yutaka Yasui; Leslie L Robison; Charles A Sklar Journal: J Clin Endocrinol Metab Date: 2006-02-21 Impact factor: 6.134
Authors: Emma S Gargus; Hunter B Rogers; Kelly E McKinnon; Maxwell E Edmonds; Teresa K Woodruff Journal: Nat Biomed Eng Date: 2020-04-06 Impact factor: 25.671
Authors: Lisa M Pastore; Mindy S Christianson; James Stelling; William G Kearns; James H Segars Journal: J Assist Reprod Genet Date: 2017-10-02 Impact factor: 3.412
Authors: A Falorni; V Minarelli; C M Eads; C M Joachim; L Persani; R Rossetti; P Yurttas Beim; V A Pellegrini; P F Schnatz; S Rafique; K Kissell; K A Calis; V Popat; L M Nelson Journal: Panminerva Med Date: 2014-10-07 Impact factor: 5.197